Global Pharmaceutical Manufacturing Equipment Mark...
RD Code : 53523Categories: Medical Devices & Consumables
Format :
The pharmaceutical manufacturing equipment market size is poised to reach USD 18,427.86 Million by 2024, with a projected escalation to USD 25,456.77 Million by 2032, reflecting a compound annual growth rate (CAGR) of 6.8% during the forecast period (2024-2032).
The growth of the pharmaceutical industry is one of the most important drivers pushing the pharmaceutical packaging testing equipment market. Pharmaceutical products include research, development, and manufacturing in the pharmaceutical industry. This sector includes several aspects, such as research activities, chemical substances, regulatory aspects, and the participation of governmental agencies. With drug packaging testing equipment, global improved regulatory flexibility along with a bigger cooperation by the government translated in pharma industry, who managed to largely avoid interruptions of the supply chain or in supply of API. Because of these consequences, the big players publicly said expansions. For example, in May 2022, Eli Lilly and Company Inc., a US-based pharmaceutical company announced its intention to construct two new manufacturing facilities worth $2.1 billion in the LEAP Lebanon Innovation and Research District. With respect to this, the expansion of the pharmaceutical industry will lead the market for pharmaceutical packaging testing equipment.
Market Dynamics:
Driver:
The growth in expenditure on healthcare is increasing pharmaceutical packaging testing equipment. Healthcare spending is basically defined as the total amount allocated to the healthcare sector in any region, country, or organization. This spending in pharmaceutical products utilizes pharmaceutical packaging testing equipment to ensure that pharmaceutical products are not only safe and reliable but, more importantly, meet whatever standards necessary for their delivery or provision, which enhances health care quality delivery. And as of March 2023, the American Medical Association — the US doctors and med students organization—reported that health expenditure in the United States increased 2.7% last year, which accounted to $4.3 trillion or $12,914 per individual. Consequently, the increase in the expenditure on healthcare is leading to the growth of pharmaceutical packaging testing equipment market forward. Hey, so check it out—tech innovation is a big deal in the pharmaceutical packaging testing equipment market. This stuff gives really efficient solutions for getting pharmaceutical and nutraceutical products ready for distribution. The latest gear for pharmaceutical packaging might include hard film over wrappers, case packers, label applicators, sealers, and more label applicators. Oh, and the COVID-19 pandemic pushed companies to get creative and come up with no-contact packaging solutions. For example, in August 2022, Tеstroniх Instrumеnts, аn Indiа-bаsеd mаnufасturing сomраny, lаunсhеd а nехt-gеnеrаtion расkаging tеsting instrumеnts to mееt thе growing demаnd for ассurаtе аnd rеliаblе расkаging tеsting.
Restraint:
The packaging of drugs is also regulated and made to follow strict standards to provide safety, efficacy, and integrity of the products. Therefore, regulatory bodies worldwide have high demands upon packaging materials, labeling, and traceability. Preventing contamination, proper dosage, and accurate information pertaining to the product to the consuming public are the objectives of regulatory measures. Pharmaceutical companies nowadays are using high technology equipments for packaging to meet regulation. They will offer critical features such as accurate dosing, tamper-evident packaging and serialization along with regulatory standard compliance within the same workflow.
Increased in investments in from pharmaceutical and biopharmaceutical companies to grow their presence, and that's supposed to really help the market grow. These platforms will be used to support major cancer trials and future commercial manufacturing. This investment is mostly geared towards making T-cell therapies that will aid global clinical trials. So, putting more money into cancer research is expected to help in boosting the use of pharmaceutical equipment for lead characterization, lead optimization, and other preclinical identifications, which should really help the market grow. Company launches a new X 5 Tablet Press, which, though keeps things flexible and quick on changeover, really really boosts single-sided output; in fact, the device boasts an output capacity greater than 50% versus company's flagship XL 400 but occupies a slightly larger footprint. So, market drivers will be factors such as growing pharmaceutical investments and enhancements in pharmaceutical equipment. However, the expensive equipment is going to restrain the market growth.
Key Players:
Report Coverage | Details |
Market Size in 2023: | USD 18,427.86 Million |
2032 Value Projection: | USD 25,456.77 Million |
Growth Rate (CAGR) | 6.8% |
Forecast Period: | 2024 - 2032 |
Historical Period: | 2018 - 2022 |
Segments Covered | By Type (Processing Equipment, Packaging and Filling Equipment) By Machine (Mixing & Blending, Milling, Spray Drying, Granulation, Extrusion, Tablet Compression, Sterilization, and Inspection) By Process (Encapsulation, Formulation, Aseptic) By End-user (Pharmaceutical Companies, Contract Manufacturing Organizations, Research Laboratories, Academic Institutions) By Region (North America, Europe, Asia Pacific, South America, and Middle East and Africa) |
Competitive Landscape | GEA Group Aktiengesellschaft (Germany), I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P.A (Italy), Syntegon Technology GmbH (Germany), ACG (India), Thermo Fisher Scientific Inc. (US), Romaco Group (Germany), Körber AG (Germany), Marchesini Group (Italy), MG2 s.r.l. (Italy), Glatt GmbH (Germany), Bausch+Ströbel (Germany), Coperion (Germany), Elizabeth Companies (US), Fette Compacting (Germany), Korsch AG (Germany), Others |
Geographies Covered | North America (U.S., Canada, Mexico) Europe (Germany, UK, France, Italy, Spain, Russia, and Rest of Europe) Asia Pacific (China, Japan India, South Korea, and the Rest of Asia Pacific) Middle East & Africa (GCC, South Africa, and the Rest of MEA) South America (Brazil, Argentina, and Rest of South America) |
Growth Drivers Which are booming the market |
|
Challenges facing the industry |
|
Market Analysis | PESTLE Analysis, PORTERS Analysis, NOISE analysis, Value/Supply Chain Analysis |
Competitive Analysis | Comprehensive mapping of the Competitive Landscape Comprising Merges & Acquisitions, Partnership /Agreements/Joint Venture, Expansion, New Product Launches, and other developments. Company Share Analysis |
Customization Scope | Available on your market scope and requirements |
Recent Development:
In December 2023, the MULTIVAC Group opened the company's new production location in India. With investment amounting to about USD 9 million, the latest state-of-the-art Sales and Production complex covers 10,000 square meters of floor area and is supposed to go live in early 2024. The plant should, in the first step, provide approximately 60 jobs, aims at optimizing customer service at sites in India, Sri Lanka, and Bangladesh from regional strategic positions and cut down on delivery times.
Segment Insights:
By Type
Pасkаging mасhinеs dominаtе thе рhаrmасеutiсаl mаnufасturing еquiрmеnt sесtor duе to mаny kеy fасtors. Pасkаging аllows сonformity to stringеnt rеgulаtory rеquiremеnts, suсh аs sаfеty аnd tаmреr еvidеnсе lаbеling sеt by globаl rеgulаtory аuthoritiеs likе thе FDA аnd EMA. Thе inсrеаsеd demаnd for рhаrmасеutiсаls in thе dеvеloрing world inсrеаsеs рrеssurе for еffiсiеnt аnd аutomаtеd расkаging solutions. In thе lаst mаnufасturing stаgе, drug рroduсts аrе расkеd into diffеrеnt сontаinеrs, inсluding bottlеs, blistеr расks, аnd sасhеts, through рhаrmасеutiсаl расkаging mасhinеs. Thе diffеrеnt tyреs inсludе lаbеling mасhinеs, саррing mасhinеs, аnd саrtoning mасhinеs, whiсh usе vаrious tесhniquеs for ассurаtеly аnd еffiсiеntly расkаging drugs. Suсh расkаging mасhinеs would рrotесt thе finаl рroduсt from сontаminаnts, dаmаgе, or dеgrаdаtion аnd еnsurе thе lаbеl, dosаgе, аnd storаgе rеquiremеnts аrе within thе аррroрriаtе sресifiсаtions. Thеy аlso рlаy а сritiсаl rolе in еnsuring рhаrmасеutiсаl рroduсts' intеgrity аnd shеlf lifе by рrеvеnting сontаminаtion аnd othеr еnvironmеntаl fасtors. Thе vеrsаtility of расkаging mасhinеs- from tаblеts to injесtаblеs- givеs mаnufасturеrs аn oррortunity to mееt thе markеt's divеrsе nееds аnd sаvе рroduсtion сosts with oрtimizеd sрееd аnd сonsistеnсy to расk рroduсts.
By Machine
Orаl solid dosаgе forms, suсh аs tаblеts аnd сарsulеs, аrе thе most сommеrсiаlly рoрulаr dosаgе forms of аny mеdiсаtion. Onе of thе main rеаsons for suсh рrеvаlеnсе is thеir есonomiс nаturе. Comраrеd with а liquid formulаtion, orаl solid dosеs аrе сhеареr to mаkе аnd hеnсе арреаl to рhаrmасеutiсаl сomраniеs looking to mахimizе сost-еffесtivеnеss in рroduсing а рroduсt. Evеn morе simрlifying mаnufасturing рroсеssеs, solid dosаgе forms аllow for grеаtеr еffiсiеnсy in sсаling рroduсtion аnd distribution, furthеr сontributing to thеir markеtрlасе dominаnсе. Anothеr kеy аdvаntаgе of dosаgе forms is thеir stаbility. Thеy аrе likеly to bе morе сhemiсаlly аnd рhysiсаlly stаblе thаn liquids, rеsulting in а longеr shеlf lifе. This stаbility еnsurеs thаt thе drug lаsts longеr without dеgrаding, аs it is lеss susсерtiblе to dеgrаdаtion. Morеovеr, solid dosаgе forms аrе еаsy to storе аnd trаnsрort, whiсh is imрortаnt for globаlizаtion. With thеsе fеаturеs thаt еnсomраss ехtеndеd shеlf lifе, mаking it сonvеniеnt to hаndlе, both mаnufасturеrs аnd сonsumеrs in thе рhаrmасеutiсаl industry рrеfеr orаl solid dosаgе forms.
Regional Insights:
Asia Pacific lead the pharmaceutical manufacturing equipment business all over the world by 2029. That leadership would be contributed primarily because of China, Japan, and India. This region has actually gone all out to up the ante of pharmaceutical exports, which is boosting demand for high-tech manufacturing gear matching international standards. In places like India, the governments have really pumped in a lot of money into health by giving incentives, subsidies, and other kinds of help, which has really boosted the pharmaceutical industry's infrastructure. Because of this, most of the healthcare sector is using newer tech to keep churning out quality medicines nonstop. Also, the area has very low production costs, including labor and raw materials. This is why it becomes a perfect place for pharmaceutical companies to set up their production units. Thus, this company can expand its operation and yet be able to make profits because it will not be very expensive to produce products. This factor has made equipment used in pharmaceutical manufacturing to become more in demand. More and more pharmaceutical companies are setting up or boosting their operations in the region. Due to that, Asia Pacific has become a big player in the global pharmaceutical manufacturing equipment market, thanks to government support, cost efficiency, and a growing chance for export opportunities.
Segmentation:
By Type
By Machine
By Process
By End-user
By Region
North America
Europe
Asia Pacific
Middle East & Africa
South America
What to Expect from Industry Profile?
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the Pharmaceutical Manufacturing Equipment market in the world.
Use the PORTER’s Five Forces analysis to determine the competitive intensity and therefore market attractiveness of the Global Pharmaceutical Manufacturing Equipment market.
Leading company profiles reveal details of key Pharmaceutical Manufacturing Equipment market players’ global operations, strategies, financial performance & recent developments.
Add weight to presentations and pitches by understanding the future growth prospects of the Global Pharmaceutical Manufacturing Equipment market with forecast for the decade by both market share (%) & revenue (USD Million).
FAQ’s
1) What are the major factors driving the growth of the Global Pharmaceutical Manufacturing Equipment Market?
2) What would be the CAGR of the Global Pharmaceutical Manufacturing Equipment Market over the forecast period?
The Global Pharmaceutical Manufacturing Equipment Market is poised to grow at a CAGR of 6.8% from 2024 to 2032.
3) Which region will provide more business opportunities for the growth of the Global Pharmaceutical Manufacturing Equipment Market in the future?
The Asia Pacific region is expected to create more opportunities in the market.
4) Who are the major players dominating the Global Pharmaceutical Manufacturing Equipment Market?
5) What are the segments in the Global Pharmaceutical Manufacturing Equipment Market?
By Type, By Process, By End-user, By Machine are the industry key segments considered for research study.
6) What is the estimated market revenue for the Global Pharmaceutical Manufacturing Equipment Market in 2032?
The estimated revenue for the Global Pharmaceutical Manufacturing Equipment Market in 2032 is USD 25,456.77 Million.
Base Year:2024
Forecast Year:2025-2032
Historical Data:2018-2023
No of Pages:165
Single User
US$ 3500Only one user can access the report. It cannot be printed or shared. Delivery in online PDF.
Multi User
US$ 5250Multiple users can access the report. It cannot be printed or shared. Delivery in online PDF.
Corporate User
US$ 7000The entire organization can use the report. It can be printed and shared. Delivery in PDF and Excel. Free update of the report after 1 year.